Concepts (234)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 31 | 2023 | 8305 | 1.760 |
Why?
|
| Neural Stem Cells | 6 | 2021 | 865 | 0.870 |
Why?
|
| Amyloid beta-Peptides | 17 | 2023 | 3743 | 0.870 |
Why?
|
| Neurogenesis | 7 | 2023 | 840 | 0.860 |
Why?
|
| Presenilin-1 | 11 | 2020 | 635 | 0.840 |
Why?
|
| Amyloid Precursor Protein Secretases | 7 | 2022 | 594 | 0.750 |
Why?
|
| Neprilysin | 1 | 2023 | 448 | 0.740 |
Why?
|
| Cell Culture Techniques | 4 | 2016 | 1654 | 0.710 |
Why?
|
| Hippocampus | 9 | 2023 | 3687 | 0.590 |
Why?
|
| Amyloid beta-Protein Precursor | 9 | 2022 | 1100 | 0.560 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2018 | 595 | 0.480 |
Why?
|
| Fibronectins | 3 | 2023 | 720 | 0.440 |
Why?
|
| Microglia | 4 | 2021 | 1308 | 0.430 |
Why?
|
| Cognition | 7 | 2023 | 6782 | 0.390 |
Why?
|
| Dentate Gyrus | 3 | 2008 | 161 | 0.370 |
Why?
|
| Plaque, Amyloid | 4 | 2020 | 740 | 0.330 |
Why?
|
| Memory | 6 | 2006 | 2168 | 0.290 |
Why?
|
| Astrocytes | 4 | 2023 | 1301 | 0.280 |
Why?
|
| Physical Conditioning, Animal | 2 | 2021 | 363 | 0.270 |
Why?
|
| Maze Learning | 4 | 2008 | 475 | 0.270 |
Why?
|
| Prealbumin | 1 | 2007 | 211 | 0.260 |
Why?
|
| Mice, Transgenic | 11 | 2020 | 9513 | 0.250 |
Why?
|
| Neurons | 11 | 2023 | 9292 | 0.250 |
Why?
|
| Space Perception | 1 | 2006 | 461 | 0.210 |
Why?
|
| Mice | 28 | 2023 | 80251 | 0.200 |
Why?
|
| Exercise | 1 | 2018 | 5688 | 0.200 |
Why?
|
| Graphite | 1 | 2022 | 75 | 0.200 |
Why?
|
| Aspartic Acid Endopeptidases | 2 | 2022 | 311 | 0.180 |
Why?
|
| Cell Differentiation | 7 | 2018 | 11384 | 0.180 |
Why?
|
| Interleukin-3 | 1 | 2021 | 421 | 0.180 |
Why?
|
| Adult Stem Cells | 2 | 2013 | 216 | 0.170 |
Why?
|
| Brain | 9 | 2023 | 26597 | 0.170 |
Why?
|
| Choline | 1 | 2001 | 502 | 0.170 |
Why?
|
| Disease Models, Animal | 14 | 2021 | 17869 | 0.170 |
Why?
|
| Peptide Fragments | 5 | 2002 | 5036 | 0.160 |
Why?
|
| Cell Death | 4 | 2018 | 1666 | 0.160 |
Why?
|
| Motor Activity | 1 | 2008 | 2670 | 0.160 |
Why?
|
| Animals | 35 | 2023 | 166558 | 0.160 |
Why?
|
| Models, Biological | 1 | 2014 | 9455 | 0.150 |
Why?
|
| Cell Proliferation | 5 | 2018 | 10311 | 0.150 |
Why?
|
| Hormones | 1 | 2021 | 875 | 0.150 |
Why?
|
| Carbazoles | 1 | 2018 | 220 | 0.140 |
Why?
|
| Memory Disorders | 2 | 2023 | 1175 | 0.140 |
Why?
|
| Down-Regulation | 1 | 2023 | 2908 | 0.130 |
Why?
|
| Learning | 2 | 2023 | 1719 | 0.130 |
Why?
|
| Stem Cells | 1 | 2008 | 3513 | 0.130 |
Why?
|
| Molecular Imaging | 1 | 2020 | 824 | 0.110 |
Why?
|
| Presenilin-2 | 3 | 2008 | 95 | 0.110 |
Why?
|
| Mice, Knockout | 8 | 2021 | 14253 | 0.110 |
Why?
|
| Receptors, Immunologic | 1 | 2019 | 1415 | 0.110 |
Why?
|
| Extracellular Space | 1 | 2014 | 569 | 0.110 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2014 | 413 | 0.110 |
Why?
|
| Cells, Cultured | 9 | 2021 | 18905 | 0.100 |
Why?
|
| Neurites | 1 | 2014 | 382 | 0.100 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2007 | 3985 | 0.100 |
Why?
|
| Interleukin-6 | 2 | 2019 | 3161 | 0.100 |
Why?
|
| ADAM Proteins | 1 | 2013 | 242 | 0.100 |
Why?
|
| Mice, Inbred C3H | 2 | 2013 | 908 | 0.100 |
Why?
|
| Gene Expression Regulation | 5 | 2019 | 11865 | 0.100 |
Why?
|
| Neuroprotective Agents | 3 | 2002 | 950 | 0.090 |
Why?
|
| Cell Cycle Proteins | 1 | 2022 | 3409 | 0.090 |
Why?
|
| Alkaloids | 2 | 2003 | 187 | 0.090 |
Why?
|
| Gliosis | 3 | 2013 | 243 | 0.090 |
Why?
|
| Mice, Inbred ICR | 3 | 2006 | 341 | 0.090 |
Why?
|
| Lateral Ventricles | 1 | 2010 | 141 | 0.080 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2014 | 1082 | 0.080 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2014 | 1351 | 0.080 |
Why?
|
| Enzyme Inhibitors | 3 | 2017 | 3699 | 0.080 |
Why?
|
| Molecular Chaperones | 1 | 2013 | 736 | 0.080 |
Why?
|
| Epigenesis, Genetic | 1 | 2022 | 3654 | 0.080 |
Why?
|
| Models, Neurological | 2 | 2015 | 1748 | 0.080 |
Why?
|
| Membrane Glycoproteins | 1 | 2019 | 3659 | 0.080 |
Why?
|
| Skin Neoplasms | 1 | 2007 | 5685 | 0.080 |
Why?
|
| Scopolamine | 2 | 2006 | 94 | 0.080 |
Why?
|
| Muscarinic Antagonists | 2 | 2006 | 134 | 0.070 |
Why?
|
| tau Proteins | 2 | 2015 | 2013 | 0.070 |
Why?
|
| Splenomegaly | 1 | 2007 | 188 | 0.070 |
Why?
|
| Caenorhabditis elegans | 1 | 2016 | 1423 | 0.070 |
Why?
|
| Gene Deletion | 2 | 2021 | 2665 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 6 | 2021 | 21600 | 0.070 |
Why?
|
| Crosses, Genetic | 1 | 2007 | 748 | 0.070 |
Why?
|
| Mutant Proteins | 1 | 2008 | 490 | 0.070 |
Why?
|
| Humans | 25 | 2023 | 746630 | 0.070 |
Why?
|
| Prosencephalon | 1 | 2008 | 300 | 0.070 |
Why?
|
| Rats, Long-Evans | 1 | 2006 | 372 | 0.060 |
Why?
|
| Receptors, Notch | 1 | 2010 | 735 | 0.060 |
Why?
|
| Nerve Degeneration | 2 | 2007 | 740 | 0.060 |
Why?
|
| Up-Regulation | 2 | 2020 | 4118 | 0.060 |
Why?
|
| Bromodeoxyuridine | 3 | 2010 | 310 | 0.060 |
Why?
|
| Mutation, Missense | 1 | 2013 | 2541 | 0.060 |
Why?
|
| Amyloid | 1 | 2009 | 810 | 0.060 |
Why?
|
| Rats | 9 | 2010 | 23696 | 0.060 |
Why?
|
| Protein Isoforms | 1 | 2008 | 1689 | 0.060 |
Why?
|
| Phosphorylation | 1 | 2014 | 8294 | 0.060 |
Why?
|
| Kynurenine | 1 | 2004 | 140 | 0.060 |
Why?
|
| Social Environment | 1 | 2008 | 1009 | 0.060 |
Why?
|
| Microfluidics | 1 | 2009 | 662 | 0.060 |
Why?
|
| Polygala | 1 | 2002 | 2 | 0.050 |
Why?
|
| Cognition Disorders | 3 | 2021 | 3958 | 0.050 |
Why?
|
| Cytochrome c Group | 1 | 2002 | 123 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2022 | 12044 | 0.050 |
Why?
|
| Cell Survival | 4 | 2013 | 5764 | 0.050 |
Why?
|
| Cholinesterase Inhibitors | 2 | 2002 | 237 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2004 | 1250 | 0.050 |
Why?
|
| Membrane Proteins | 2 | 2013 | 7786 | 0.050 |
Why?
|
| Injections, Intraventricular | 1 | 2001 | 224 | 0.050 |
Why?
|
| Pyruvate Dehydrogenase Complex | 1 | 2001 | 63 | 0.050 |
Why?
|
| Cues | 1 | 2006 | 868 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 4 | 2010 | 4399 | 0.050 |
Why?
|
| Sodium Glutamate | 1 | 2000 | 21 | 0.050 |
Why?
|
| Phytotherapy | 1 | 2002 | 289 | 0.050 |
Why?
|
| Food Additives | 1 | 2000 | 23 | 0.050 |
Why?
|
| Neurotoxins | 1 | 2001 | 238 | 0.040 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2022 | 234 | 0.040 |
Why?
|
| Acute-Phase Reaction | 1 | 2019 | 89 | 0.040 |
Why?
|
| Acetylcysteine | 1 | 2000 | 262 | 0.040 |
Why?
|
| Acetylcholine | 1 | 2001 | 627 | 0.040 |
Why?
|
| Plant Extracts | 1 | 2002 | 490 | 0.040 |
Why?
|
| Mitochondria | 2 | 2002 | 3528 | 0.040 |
Why?
|
| Mutation | 4 | 2015 | 29627 | 0.040 |
Why?
|
| Adult | 2 | 2023 | 215192 | 0.040 |
Why?
|
| Animals, Genetically Modified | 2 | 2016 | 1541 | 0.040 |
Why?
|
| Aspartic Acid | 1 | 2000 | 575 | 0.040 |
Why?
|
| Receptors, Nicotinic | 1 | 2001 | 495 | 0.040 |
Why?
|
| Allosteric Site | 1 | 2017 | 102 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2007 | 4043 | 0.040 |
Why?
|
| Carbon Dioxide | 1 | 2001 | 1144 | 0.040 |
Why?
|
| Male | 11 | 2020 | 351420 | 0.040 |
Why?
|
| Behavior, Animal | 2 | 2021 | 1848 | 0.040 |
Why?
|
| Disease Progression | 3 | 2008 | 13317 | 0.030 |
Why?
|
| Peptides | 1 | 2009 | 4321 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2004 | 2589 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 19819 | 0.030 |
Why?
|
| Interleukin-8 | 1 | 2019 | 689 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2010 | 23154 | 0.030 |
Why?
|
| Nicotine | 1 | 2001 | 673 | 0.030 |
Why?
|
| Embryonic Development | 1 | 2000 | 706 | 0.030 |
Why?
|
| Cricetulus | 1 | 2017 | 817 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2013 | 17445 | 0.030 |
Why?
|
| Hypothalamus | 1 | 2000 | 994 | 0.030 |
Why?
|
| Neuronal Plasticity | 1 | 2003 | 1420 | 0.030 |
Why?
|
| CHO Cells | 1 | 2017 | 1394 | 0.030 |
Why?
|
| Macaca mulatta | 1 | 2020 | 2328 | 0.030 |
Why?
|
| Estradiol | 1 | 2001 | 1945 | 0.030 |
Why?
|
| Cell Communication | 1 | 2021 | 1625 | 0.030 |
Why?
|
| Salmonella typhimurium | 1 | 2016 | 340 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2019 | 1524 | 0.030 |
Why?
|
| Cytokines | 1 | 2008 | 7236 | 0.030 |
Why?
|
| Survival Rate | 1 | 2007 | 12645 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2001 | 2168 | 0.030 |
Why?
|
| Matched-Pair Analysis | 1 | 2013 | 282 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2013 | 417 | 0.030 |
Why?
|
| Age Factors | 3 | 2018 | 18157 | 0.020 |
Why?
|
| Apoptosis | 2 | 2004 | 9447 | 0.020 |
Why?
|
| PC12 Cells | 2 | 2001 | 316 | 0.020 |
Why?
|
| Caspases | 2 | 2004 | 884 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2004 | 2817 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2017 | 3959 | 0.020 |
Why?
|
| Silver Staining | 1 | 2008 | 63 | 0.020 |
Why?
|
| Miniaturization | 1 | 2009 | 156 | 0.020 |
Why?
|
| Dementia | 1 | 2003 | 2546 | 0.020 |
Why?
|
| Gene Expression | 1 | 2021 | 7590 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2022 | 35797 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2003 | 8131 | 0.020 |
Why?
|
| Female | 5 | 2018 | 382450 | 0.020 |
Why?
|
| Surface Properties | 1 | 2009 | 1154 | 0.020 |
Why?
|
| Reference Values | 1 | 2013 | 4879 | 0.020 |
Why?
|
| Cell Line | 2 | 2015 | 15642 | 0.020 |
Why?
|
| Sample Size | 1 | 2009 | 832 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2001 | 5717 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2013 | 11050 | 0.020 |
Why?
|
| Synucleins | 1 | 2004 | 107 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2008 | 2568 | 0.020 |
Why?
|
| Cell Division | 2 | 2003 | 4440 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 2047 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2016 | 3025 | 0.010 |
Why?
|
| Phenotype | 1 | 2021 | 16261 | 0.010 |
Why?
|
| Cell Count | 1 | 2007 | 1833 | 0.010 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2004 | 288 | 0.010 |
Why?
|
| Transfection | 1 | 2010 | 5789 | 0.010 |
Why?
|
| Digestive System | 1 | 2003 | 245 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2013 | 21693 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2010 | 6226 | 0.010 |
Why?
|
| Liver Function Tests | 1 | 2003 | 521 | 0.010 |
Why?
|
| Estrogen Antagonists | 1 | 2001 | 151 | 0.010 |
Why?
|
| DNA, Antisense | 1 | 2000 | 44 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 2003 | 1315 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 2001 | 458 | 0.010 |
Why?
|
| Cell Membrane Permeability | 1 | 2002 | 581 | 0.010 |
Why?
|
| Hemolysis | 1 | 2003 | 420 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2002 | 729 | 0.010 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2002 | 447 | 0.010 |
Why?
|
| Infusions, Parenteral | 1 | 2000 | 405 | 0.010 |
Why?
|
| Cyclosporine | 1 | 2002 | 751 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2001 | 509 | 0.010 |
Why?
|
| S Phase | 1 | 2000 | 412 | 0.010 |
Why?
|
| Nervous System | 1 | 2003 | 540 | 0.010 |
Why?
|
| Respiratory System | 1 | 2003 | 554 | 0.010 |
Why?
|
| Fear | 1 | 2008 | 1440 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 2003 | 922 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2004 | 3602 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 2001 | 912 | 0.010 |
Why?
|
| Entorhinal Cortex | 1 | 2000 | 278 | 0.010 |
Why?
|
| Avoidance Learning | 1 | 2000 | 244 | 0.010 |
Why?
|
| alpha-Synuclein | 1 | 2004 | 731 | 0.010 |
Why?
|
| Calcium Signaling | 1 | 2002 | 721 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2013 | 12767 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2003 | 2657 | 0.010 |
Why?
|
| Autonomic Nervous System | 1 | 2003 | 677 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2010 | 4487 | 0.010 |
Why?
|
| Amnesia | 1 | 2000 | 258 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 2002 | 1154 | 0.010 |
Why?
|
| Tamoxifen | 1 | 2001 | 957 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2004 | 2075 | 0.010 |
Why?
|
| Rabbits | 1 | 2003 | 4788 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2000 | 1520 | 0.010 |
Why?
|
| Fetus | 1 | 2002 | 1882 | 0.010 |
Why?
|
| Cerebral Infarction | 1 | 2000 | 978 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2000 | 1658 | 0.010 |
Why?
|
| Microtubules | 1 | 2000 | 1078 | 0.010 |
Why?
|
| Aging | 1 | 2013 | 8486 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2001 | 3789 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 15386 | 0.010 |
Why?
|
| Synapses | 1 | 2003 | 1738 | 0.010 |
Why?
|
| Reaction Time | 1 | 2000 | 2076 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2001 | 2464 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2003 | 4189 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2001 | 2128 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2000 | 2898 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2001 | 10750 | 0.000 |
Why?
|
| Environmental Exposure | 1 | 2003 | 4315 | 0.000 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 16667 | 0.000 |
Why?
|
| Longitudinal Studies | 1 | 2003 | 14124 | 0.000 |
Why?
|
| Pregnancy | 1 | 2000 | 29297 | 0.000 |
Why?
|
Concepts
(234)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(33)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_